CHERNOV, KONSTANTIN EVSTAFYEVICH,CHERNOV, ALEKSEY KONSTANTINOVICH
申请号：
CA2851121
公开号：
CA2851121A1
申请日:
2011.08.05
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
The invention relates to a method for treating skin diseases using live "Penicillium notatum" fungus. There is still little known about the "Penicillium notatum" fungus. Live "Penicillium notatum" fungus acts in the following ways in the treatment process: 1) as a biological producer of the most effective antibiotic against (particular) pathogenic microorganisms which act as the causative agents of a particular disease； 2) as a biological therapeutic vehicle for the efficient delivery of an antibiotic individually to each pathogenic microorganism； 3) as a biological vehicle for the removal of dead and infected human body tissue； 4) as a biological immunizing agent that protects young, regenerating skin； 5) as a biological immunizing agent that protects young skin tissue that has not established immunity against repeated attack from the disease following regeneration. The treatment period for certain infectious skin diseases using live "Penicillium notatum" fungus lasts from three to five days. In the future, it is possible that the live fungus "Penicillium notatum" is used to augment the immunity lost by people under various specific circumstances, such as specific conditions of work and day-to-day activity, a prolonged period in space, loss or reduction in constant gravitational weight, impaired individual immunity caused by space-related factors, and the emergence of new diseases. It can supplement or replace the immunizing microflora of human internal organs. It is likely that the fungus will be domesticated and new species thereof artificially derived specifically for each organ of the human body. It is essential that mankind learns how to use the live fungus "Penicillium notatum" in the field of medicine in view of the fact that its resilience exceeds that of all life forms known to mankind, including the resilience of the microorganisms of the immunizing human microflora.
